Vasoepididymostomy

Vasoepididymostomy is a surgical procedure performed to restore the function of the male reproductive system. It is often used in cases where there is a blockage in the epididymis, a tube located at the back of the testicles that stores and carries sperm. This procedure is considered one of the most technically challenging operations in the field of microsurgery.

Procedure

The vasoepididymostomy procedure involves the connection of the vas deferens, a duct that conveys sperm from the testicle to the urethra, to the epididymis. This is done in an attempt to bypass any blockages that may be present in the epididymis and restore the flow of sperm.

The procedure is typically performed under general anesthesia. The surgeon makes a small incision in the scrotum to expose the testicle and the epididymis. The blocked section of the epididymis is then bypassed by connecting the vas deferens directly to an unblocked portion of the epididymis.

Indications

Vasoepididymostomy is typically indicated in cases of obstructive azoospermia, a condition characterized by the absence of sperm in the semen due to a blockage in the male reproductive tract. This blockage can be caused by a variety of factors, including previous vasectomy, infection, or congenital defects.

Risks and Complications

As with any surgical procedure, vasoepididymostomy carries some risks. These may include infection, bleeding, and damage to the surrounding tissues. There is also a risk that the procedure may not be successful in restoring sperm flow.

Success Rates

The success rate of vasoepididymostomy varies widely, depending on factors such as the surgeon's skill, the specific cause of the blockage, and the patient's overall health. In general, however, success rates for this procedure are relatively high.

See Also

• Microsurgery
• Vasectomy
• Azoospermia
• Male reproductive system

Vasoepididymostomy Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.